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Purpose: We compared outcomes of the U- and H-type approaches of the tension-free 
vaginal tape (TVT)-Secur procedure for the treatment of female stress urinary incon-
tinence (SUI). 
Materials and Methods: From March 2007 to July 2008, 115 women with SUI underwent 
TVT-Secur by a single surgeon. Patients were randomly assigned to either the U- or 
the H-type approach. After 12 months, postoperative changes in the Sandvik ques-
tionnaire, incontinence quality of life questionnaire (I-QoL), Bristol female lower uri-
nary tract symptoms-scored form (BFLUTS-SF), and postoperative patient satisfaction 
were evaluated. Cure was regarded as no leakage on the Sandvik questionnaire. Compli-
cations were also evaluated.
Results: Of 115 women, 53 were treated with the U approach, and 62 women were treat-
ed with the H approach. At 12 months, 88.7% of those treated with the U approach and 
87.1% of those treated with the H approach were cured (p=0.796). The I-QoL and filling, 
incontinence, sexual function, and QoL sum (BFLUTS-SF) scores were improved with 
both approaches, and there were no significant differences in the degree of improvement 
between approaches. Approximately 83.7% and 82.9% of the women treated with the 
U and H approaches, respectively, were satisfied with the outcome (p=0.858). There 
were 3 cases of intra-operative vaginal wall perforation in the H-type group. Immediate 
postoperative retention was observed in 2 women in the U-type group and 1 woman 
in the H-type group. One woman in the U-type group underwent tape releasing and 
cutting procedures for persistent large post-void residuals. 
Conclusions: The U- and the H-type approaches of the TVT-Secur procedure provided 
comparable effectiveness for the treatment of female SUI.
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INTRODUCTION
Urinary incontinence affects up to 50% of women, resulting 
in a significant medical, social, and economic burden [1,2]. 
The annual direct costs of incontinence in the United States 
were estimated to be more than $16 billion [3]. Among wom-
en with incontinence, 50% to 80% are identified as having 
stress urinary incontinence (SUI), or involuntary leakage 
of urine resulting from physical exertion or sneezing and 
coughing. [4,5]. Similar to its frequency in Western coun-
tries, about 37.8% of Korean adult women suffer from SUI 
[6]. Although the initial treatment of stress incontinence 
is often nonsurgical (behavioral therapy, pelvic-floor exer-
cises, or incontinence devices), surgical treatment is consi-
dered for patients who are bothered by persistent symp-
toms. An estimated 4% to 10% of women in the United 
States undergo surgery intended to restore continence, and 
this rate has increased steadily during the past 20 years 
[7].
　At present, one of the most successful treatments for SUI 
is provided by surgery. Burch corposuspension was once 
the standard technique, but tension-free vaginal tape 
(TVT) is now the gold standard. TVT is a minimally in-
vasive procedure with a cure rate comparable to Burch cor-Korean J Urol 2010;51:250-256
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posuspension in an appropriate randomized control study 
[8,9]. However, TVT has the risk of serious complications 
associated with the ‘blind’ course of the needle through the 
retropubic space. Therefore, bladder perforation as well as 
vascular and bowel injuries are occasionally reported [10- 
12]. For obviation of needle passage through the retropubic 
space, the trans-obturator sling was introduced. The trans- 
obturator sling procedure demonstrated a comparable 
cure rate but fewer complications associated with needle 
passage through the retropubic space [13,14]. However, 
the trans-obturator sling can induce entrapment of the ob-
turator nerve, and groin and upper thigh pain occasionally 
occur [15]. Furthermore, there are reports of nerve and vas-
cular injuries as well as fasciitis [16]. Therefore, further im-
provement of the surgical methods for the treatment of SUI 
is needed.
　The TVT-Secur system was developed to reduce the in-
vasiveness of the surgical procedures and to avoid passing 
the needle through the retropubic or obturator regions. The 
advantages of this technique are related to the short course 
of the needles, which minimizes the risk of vascular, nerve, 
or visceral injury. The prosthetic implant is placed under 
the midurethra and can be fixed in the hammock (H) posi-
tion into the obturator internus muscle or in the U-shaped 
position into the connective tissue of the urogenital dia-
phragm behind the pubic bone. Some concerns may arise 
regarding the strength of the fixation point and the tension-
ing maneuver. Comparative studies of the surgical out-
come between approaches are lacking. 
　Herein, we conducted a prospective, randomized, com-
parative study to compare effectiveness and safety be-
tween the H and U approaches of the TVT-Secur procedure 
for the treatment of female SUI.
MATERIALS AND METHODS
This was a 12-month, randomized trial involving one expe-
rienced surgeon at a single medical center. Participants re-
ceived detailed information about the study procedure and 
provided written consent before study entry. Consenting 
patients were randomly allocated to either the U-type or 
the H-type method immediately.
　Women who were 18 years old or older and presented 
with urodynamic SUI for at least 3 months were selected 
for this study. Patients with a history of prior anti-incon-
tinence surgery or ≥stage 2 pelvic organ prolapse were 
excluded. Baseline measures included patient demogra-
phics, detailed medical and surgical history, and obstetric 
and gynecological history. All women underwent a phys-
ical examination for urethral hypermobility, as measured 
by the Q-tip test, and pelvic-organ prolapse. Preoperati-
vely, we assayed women by a urodynamic study, Sandvik 
questionnaire, incontinence quality of life questionnaire 
(I-QoL), Bristol female lower urinary tract symptoms-scored 
form (BFLUTS-SF) questionnaire, incontinence visual an-
alogue scale (I-VAS), 3-day voiding diary, and uroflow-
metry. Just after the decision of surgery, informed consent 
was gained. At the 12-month follow-up, changes in the I- 
QoL questionnaire, BFLUTS-SF questionnaire, I-VAS, 
3-day voiding diary, and uroflowmetry were assessed; com-
plications were also assessed. Patients’ perception of treat-
ment benefit, satisfaction, and willingness to undergo re-
treatment or recommend treatment were also evaluated. 
Cure was defined as no leakage during stress after surgery 
at the 12-month postoperative visit. 
　The primary endpoint was the difference in the cure rate 
of SUI between the H- and U-type approaches. The secon-
dary endpoints included differences in 1) postoperative 
changes in I-QoL, BFLUTS-SF, I-VAS, uroflowmetry, and 
voiding diary; 2) patients’ perception of treatment benefit, 
satisfaction, and willingness to undergo retreatment or 
recommend treatment; 3) perioperative parameters (oper-
ative time, bleeding amount, and immediate postoperative 
pain VAS); and 4) return to normal activities. Overall cure 
rate and complications were also evaluated. Our institu-
tional review board approved this study, and written in-
formed consent was obtained from all participants before 
enrollment.
1. Surgical procedure 
Random allocation to either the U or the H approach was 
performed after obtaining informed consent. All opera-
tions were conducted at a day care surgery center by the 
same experienced surgeon. Under a combination of local 
anesthesia and light sedation, patients were positioned in 
the dorsal lithotomy position. After infiltrating mixed nor-
mal saline with lidocaine and 1:200,000 epinephrine into 
the anterior vaginal wall, an approximately 1.5 cm midline 
vertical vaginal incision was made from 1 cm below the ex-
ternal urethral meatus, and paraurethral dissections were 
processed bilaterally. For the U-type procedure, the in-
serter was grasped without the protective cover and using 
the needle holder, and the inserter was introduced into the 
previously dissected paraurethral incision orienting the 
inserter to 45º from the sagittal midline and toward the ip-
silateral shoulder. The inserter was advanced upward un-
til the back edge of the pubic bone was reached, keeping the 
inserter tip against the backside of the pubic bone. The nee-
dle driver was disconnected from the first inserter and was 
connected to the second inserter after removing the pro-
tective cover. The second inserter and device were placed 
in the back side of the pubic bone in the same manner. After 
disconnecting the needle holder from the second inserter, 
tension was adjusted. After the final adjustment, the re-
lease wire was pulled and the inserters were removed. For 
the H approach, dissection was made laterally, towards the 
ischiopubic ramus and parallel to the floor on both sides, 
and the inserter and device were positioned firmly into the 
obturator internus muscle. Cystoscopy was performed only 
in patients undergoing the U approach. Urethral catheters 
were not used, and patients were discharged after several 
instances of self-voiding.Korean J Urol 2010;51:250-256
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TABLE 1. Patients’ baseline characteristics
Overall (n=115) U type (n=53) H type (n=62) p-value
Age (years) 55.96±8.98 55.21±9.34 56.6±8.68 0.410
a
BMI (kg/m
2) 23.50±2.77 23.76±3.07 23.28±2.50 0.400
a
Parity (times) 2.94±1.42 2.66±1.13 3.18±1.60 0.104
a
Menopause 34 (29.82%) 17 (32.08%) 17 (27.87%) 0.624
b
Prior hysterectomy 8 (6.96%) 4 (7.55%) 4 (6.45%) 1.000
c
Symptom duration (months) 62.37±80.80 52.57±70.57 70.57±89.70 0.055
a
Symptom grade  0.916
a
  I3 9 1 8 2 1
  II 66 30 36
  III 10 5 5
Incontinence VAS 6.65±2.13 6.61±2.15 6.69±2.14 0.869
a
Urodynamic parameters
ALPP (cm H2O) 96.95±22.88 92.92±19.98 100.38±24.73 0.020
a
MUCP (cm H2O) 44.12±12.37 43.84±13.28 44.37±11.63 0.827
a
DO (n, %) 9 (8.0%) 5 (9.6%) 4 (6.6%) 0.7302
BMI: body mass index, VAS: visual analogue scale, ALPP: abdominal leak point pressure, MUCP: maximal urethral closing pressure,
DO: detrusor overactivity, 
a: wilcoxon two-sample test, 
b: chi-square test, 
c: Fisher’s exact test
FIG. 1. Participants’ diagram.
TABLE 2. Perioperative parameters
Overall (n=115) U type (n=53) H type (n=62) p-value
Operative time (min)
Intraoperative bleeding (ml)
Postoperative pain at recovery room (VAS)
14.04±5.73
61.85±61.02 
2.13±1.87 
14.77±6.35
56.45±45.31
2.18±2.00 
13.42±5.13
66.36±71.63 
2.09±1.77 
0.114
a
0.645
a
0.926
a
VAS: visual analogue scale, 
a: Wilcoxon 2-sample test
RESULTS
From March 2007 to July 2008, 115 women with SUI under-
went the TVT-Secur procedure. Of those, 53 underwent the 
U-type surgery, and 62 underwent the H-type surgery. 
Initially, 133 women were enrolled and randomly allocated Korean J Urol 2010;51:250-256
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TABLE 4. Comparison of required time for return to normal activity between the U- and H-type approaches
Days Overall (n=115) U type (n=53) H type (n=62) p-value
Time to house work 
Time to job 
Time to social activity 
Time to hobby 
Time to sexual activity 
6.22±10.95
8.03±8.98 
12.64±18.46 
12.77±13.85 
39.30±14.56 
7.18±12.15 
9.33±9.69 
14.33±20.31
14.84±15.11
38.96±15.31
5.43±9.89 
6.64±8.27 
11.41±17.17
11.08±12.67
39.56±14.20 
0.624
a
0.207
a
0.347
a
0.442
a
0.885
a
a: Wilcoxon two-sample test
to either the U-type (n=66) or the H-type (n=67) procedure. 
Of those, 13 women in the U-type group and 5 women in 
the H-type group withdrew informed consent and did not 
undergo surgery (Fig. 1).
　The mean age was 55.21±9.34 years in those receiving 
the U-type surgery and 56.6±8.68 years in those under-
going the H-type approach (p= 0.410). There were no sig-
nificant differences in preoperative patient characteristics 
or perioperative parameters between the U-type and 
H-type approaches (Table 1, 2). 
　Cure rates were 88.7% (47/53) for the U-type approach 
and 87.1% (54/62) for the H-type approach (p=0.796), with 
an overall cure rate of 87.8% after 12 months postopera-
tively. The I-QoL (total and all subscale scores), filling, in-
continence, sexual function, and QoL sum (BFLUTS-SF), 
and incontinence VAS were significantly improved with 
both approaches, but the degree of improvement did not dif-
fer significantly between the two approaches (Table 3). Re-
garding the voiding diary, micturition episodes were re-
duced with both approaches, but urgency episodes de-
creased significantly with only the H-type approach (Table 
3). The maximal flow rate did not change with either ap-
proach, but post-void residuals increased in women treated 
with the H method (Table 3). Approximately 82.9% of wom-
en treated with the U-type approach and 84.3% of those 
treated with the H-type method reported that they were 
satisfied with the surgical outcome (p=0.858). A total of 
80.5% of those treated with the U-type method and 86.3% 
of those treated with the H-type approach reported a bene-
fit from the surgery (p=0.455). About 87.8% and 88.0% 
treated with the U-type and the H-type approaches, re-
spectively, reported that they would recommend the sur-
gery to others who had SUI (p=0.442). Also, 87.8% and 
86.3% treated with the U-type and with the H-type meth-
ods reported that they would undergo the same surgery if 
they had been in same condition (p=0.800).
　Regarding intra-operative parameters, the mean dura-
tion of the operation was 14.8±6.3 min for the U-type app-
roach and 13.4±5.1 min for the H-type approach (p=0.114). 
The mean amount of blood loss was 56.4±45.3 ml for the 
U-type approach and 66.4±71.6 ml for the H-type approach 
(p=0.645). Immediate postoperative pain VAS was 2.2±2.0 
for the U-type approach and 2.1±1.8 for the H-type app-
roach (p=0.926). The time required for patients to return 
to normal activities was not significantly different between 
the approaches (Table 4). There were no patient complaints 
about dyspareunia or loss of libido after either type of pro-
cedure.
　There were 3 cases of intra-operative vaginal wall perfo-
rations during the H-type approach. All 3 cases were imme-
diately repaired, and the wound healed without infection 
or erosion. Immediate postoperative retention was ob-
served in 2 women treated with the U-type approach and 
in 1 woman treated with the H-type method. Retention was 
resolved after temporary drainage without voiding symp-
toms. One woman had tape release and additional cutting 
procedures for persistent and large amounts of residual 
urine. Overall, 4 women underwent additional midurethral 
sling procedures for persistent urine leakage. In detail, 
transobturator tape (TOT) was applied for 3 women as an 
additional sling procedure and TVT was applied for 1 
woman.
DISCUSSION
Our study demonstrated that there was no significant dif-
ference in the cure rate between the U-type and the H-type 
methods of TVT-Secur, with an approximately 88% overall 
cure rate after 1 year of follow-up, compared with previous 
studies reporting 1-year cure rates of 91% for TVT [17], 92% 
for TOT, and 86% for TVT-obturator (TVT-O) procedures 
[18]. To our knowledge, no comparative studies between 
TVT-Secur and other midurethral sling procedures such as 
TVT and TOT have been performed. Also, although there 
are some reports on TVT-Secur, no prospective compara-
tive study of the U and H methods has been carried out. In 
our study, both types of surgery demonstrated comparable 
cure rates and patient-reported outcomes at the 1-year fol-
low-up. Our study demonstrated a comparable cure rate 
with the other sling methods, including TVT, the gold 
standard treatment for female SUI. A few studies have re-
ported unfavorable outcomes for TVT-Secur [19-21]. Re-
cently, however, a prospective study reported a 1-year cure 
rate as high as 93.5% [22]. In addition, MiniArc, other types 
of midurethral slings with single-incision systems, have re-
sulted in up to 91% 1-year cure rates [23]. 
　An important point for obtaining continence is the dis-
connection of the inserter from the mesh. This entails a gen-
tle twist of the handle while gently pushing the device into 
the patient’s body. This maintains the ideal tension of the 
mesh, which should be left abutting the urethra, forcing the 
periurethral tissues to protrude slightly through the mesh Korean J Urol 2010;51:250-256
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pores. Otherwise, the mesh will not be firmly attached to 
the connective tissue and will fail to provide adequate ten-
sion to the urethra. Thus, surgeons need experience in re-
moving the inserters without loosening the mesh.
　TVT-Secur is an 8 cm long polypropylene mesh with the 
absorbable end able to be fixed to the obturator internus 
internal fascia that can be inserted through a single 1.5 cm 
vaginal incision. The extension of the dissection required 
to create a passage for the sling is very limited. Because nei-
ther sutures nor inserting needles are needed, the risk of 
internal injury inherent to the blind passage of inserting 
needles is hypothetically minimized. Because mortalities 
have been reported after midurethral slings associated 
with perineal fasciitis [16] as well as vascular and bowl in-
jury [10-12], safety must be considered when choosing the 
type of midurethral sling. In our study, 6 cases of complica-
tion were reported. There were no cases of bladder perfo-
ration, which occurs in up to 11% of TVT procedures [24]. 
Nor were there any cases of vessel injury, which usually re-
sults from the blind course of the needles and occurs in up 
to 4.0% of those treated with TVT [25]. Furthermore, no pa-
tient suffered from postoperative persistent groin or thigh 
pain due to obturator nerve entrapment by the mesh, which 
occurs in up to 14.3% of those treated with the trans-
obsturator sling series [26]. 
　The technique for placing the TVT-Secur can be rapidly 
learned by the average surgeon qualified to treat SUI. 
However, caution is required when placing the TVT-Secur 
extremities in the fibrous attachment of the internal ob-
turator muscle, because this might not be quickly achieved 
by inexperienced surgeons. No space should be left between 
the urethra and the device. The TVT-Secur needle di-
mension requires a wider tunnel, and surgeons probably 
need some experience with the procedures to find it. The 
operator must be careful to avoid vaginal perforation. In 
this study, there were 3 cases of intra-operative vaginal 
wall perforation with the H-type approach. Neuman re-
ported a 4% incidence of vaginal perforation in their first 
100 cases [22]. TVT-Secur, especially the H-type, requires 
a wider tunnel to prevent dragging of the vaginal sub-
mucosal connective tissue when placing the end of the de-
vice into the fibrous tissue of the internal obturator muscle. 
Otherwise, the needle can perforate the vaginal wall. 
Neuman also reported a 10% incidence of vaginal tape pro-
trusion, a 5% incidence of tape removal, a 2% incidence of 
bladder outlet obstruction, and a 1% incidence of para-
vesical hematoma [22]. Therefore, a surgeon must receive 
adequate training before attempting this surgery.
　Changes in post-void residuals were significantly larger 
with the H-type approach than with the U-type approach. 
TVT induces urethral obstruction more frequently than do 
trans-obturator procedures, as evidenced by ultrasono-
graphic and urodynamic findings [27,28]. Currently, it is 
unclear why the H-type approach resulted in significantly 
larger post-void residuals in our study than the U-type ap-
proach; clinically, however, the increase is thought to be 
insignificant. Furthermore, of the 3 patients with immedi-
ate postoperative urinary retention, none needed addi-
tional treatment for persistent large post-void residuals or 
voiding symptoms after removal of the temporary urethral 
catheter. 
　Urgency episodes were significantly reduced only with 
the H-type approach. Generally, studies comparing TVT 
and TOT reported no difference in de novo frequency and 
urgency [26,27]. However, the effectiveness on overactive 
bladder symptoms remains controversial. Interestingly, 
midurethral sling procedures are effective in improving 
preexisting overactive bladder symptoms in half of the pa-
tients with mixed incontinence [28,29]. Contact with urine 
in the proximal urethra can induce a reflex contraction of 
the detrusor muscle [30]. Thus, eliminating urinary leak-
age may decrease this reflex after anti-incontinence sur-
gery. At present, improvement in overactive bladder symp-
toms, including urgency and de novo urgency, after TVT- 
Secur need further study. 
　Statistically considered sample size calculation for ran-
domized controlled trials was not applied for the design of 
this study. For the calculation of an optimistic sample size, 
the investigator must have some information on both the 
variability of response to therapy and the assumed degree 
of effectiveness of therapy. But, because only a few reports 
provided information about the variability and effective-
ness of each subtype of TVT-Secur before our study, stat-
istically considered sample size calculation was not appli-
cable for this study.
　At baseline, the abdominal leak point pressure (ALPP) 
of the H-type approach group was significantly higher than 
that of the U-type group. But, because the absolute differ-
ence in mean value was just 7.46 cmH2O and the proportion 
of intrinsic sphincter deficiency (ISD, ALPP＜60 cmH2O) 
between the U-type (0.37%) and H-type (0.48%) groups was 
not significantly different (p=0.87), the difference in ALPP 
may be clinically insignificant. However, this unbalanced 
baseline characteristic could be a prognostic factor having 
a negative effect on the U group. If random allocation had 
been more balanced and clinically significant effect-size 
and power had been calculated, the surgical outcome of the 
U-type approach could have been superior to that of the 
H-type. 
　At this time, we cannot explain the exact reasons for per-
sistent urine leakage after TVT-Secur. All 4 women who 
underwent additional midurethral sling because of persis-
tent SUI after TVT-Secur were cured. Therefore, one possi-
ble explanation for failure is suboptimal urethral tension 
of TVT-Secur.
　The goal of a minimally invasive surgical procedure 
should be to provide an acceptable cure rate that is com-
parable to that of standard methods as well as a relatively 
low incidence of complications. In the context of the accept-
able cure rate and low rate of complications compared with 
TVT and TOT, our study demonstrates that with relatively 
short-term follow-up, both the U-type and the H-type ap-
proaches of the TVT-Secur procedure are equally effective 
and safe for the treatment of female SUI. Korean J Urol 2010;51:250-256
256 Kim et al
CONCLUSIONS
Both the U-type and the H-type approaches of the TVT- 
Secur system are effective procedures in terms of cure rate 
and patient-reported outcomes for the treatment of female 
SUI with 1 year of follow-up. There were no severe compli-
cations related to either approach. Studies are needed to 
establish the long-term outcomes of the procedure. 
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